← Back to headlines
Clinuvel Pharmaceuticals Reports Q3 Revenue of A$94.02 Million
Australian biotech firm Clinuvel Pharmaceuticals posted GAAP earnings of A$0.67 per share alongside quarterly revenue of A$94.02 million.
27 Aug, 09:28 — 27 Aug, 09:28
Sources
Showing 1 of 1 sources
